Statement on minimum information requirements to advertise the Engerix B® vaccine against hepatitis b

Pursuant to Article L. 5122-6 of the Public Health Code, the High Council for Public Health has determined the minimum information required to advertise the Engerix B® vaccine against hepatitis b.

Statement issued by the French Commission of experts on communicable diseases (Commission spécialisée maladies transmissibles), on the proposal of the Technical Vaccination Committee (Comité technique des vaccinations - CTV) on May 28, 2010.

Source: http://www.hcsp.fr/docspdf/avisrapports/hcspa20100528_mmo_EngerixB.pdf